Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2025-12-24 @ 11:34 PM
NCT ID:
NCT00373256
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of advanced breast cancer.
* Measurable disease as per RECIST (Response Evaluation Criterion) in Solid Tumors or bone-only disease.
* ECOG (Eastern Cooperative Oncology Group) performance status 0 or 1.
Exclusion Criteria:
* No prior treatment with cytotoxics in the advanced disease setting.
* HER2/neu positive disease unless trastuzumab was previously received or is contraindicated.
* Treatment with a taxane in the adjuvant setting unless disease free interval \>12 months after end of treatment.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00373256
Study Brief:
Protocol Section:
NCT00373256